Across TCGA pan-cancer cohorts, CLEC20A RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated CLEC20A data layer.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher CLEC20A RNA is associated with better overall survival. In most high-consensus cancer types, elevated CLEC20A expression acts as an unfavorable survival marker, although some lineages such as HNSC and OV show a favorable association.
HNSC, KICH, and ACC are the cancer types where CLEC20A RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.